219 related articles for article (PubMed ID: 10528790)
21. Fusidic acid in a tertiary hospital: an observational study focusing on prescriptions, tolerance and susceptibility of Staphylococcus and Cutibacterium spp. strains from bone samples.
Romaru J; Limelette A; Lebrun D; Bonnet M; Garnier VV; N'Guyen Y
Eur J Clin Microbiol Infect Dis; 2022 Aug; 41(8):1107-1113. PubMed ID: 35780283
[TBL] [Abstract][Full Text] [Related]
22. Long-term use of daptomycin for MRSA osteomyelitis and joint infection.
Burns CA
Scand J Infect Dis; 2008; 40(2):183-6. PubMed ID: 17852899
[TBL] [Abstract][Full Text] [Related]
23. Case report: treatment of chronic osteomyelitis.
Wolfe CR
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S538-41. PubMed ID: 21546631
[TBL] [Abstract][Full Text] [Related]
24. Oral antibiotic treatment of staphylococcal bone and joint infections in adults.
Kim BN; Kim ES; Oh MD
J Antimicrob Chemother; 2014 Feb; 69(2):309-22. PubMed ID: 24072167
[TBL] [Abstract][Full Text] [Related]
25. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella.
Saphyakhajon P; Joshi AY; Huskins WC; Henry NK; Boyce TG
Pediatr Infect Dis J; 2008 Aug; 27(8):765-7. PubMed ID: 18600193
[TBL] [Abstract][Full Text] [Related]
26. Appropriate oral antibiotics for bone and joint infections based on the susceptibility of clinical Staphylococcus aureus isolates.
Lee CS; Hwang JH; Lee JH; Song SK; Cho JH; Lee JH
Korean J Intern Med; 2015 Mar; 30(2):262-4. PubMed ID: 25750572
[No Abstract] [Full Text] [Related]
27. No change in the distribution of types and antibiotic resistance in clinical Staphylococcus aureus isolates from orthopaedic patients during a period of 12 years.
Aamot HV; Stavem K; Skråmm I
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1833-7. PubMed ID: 26076750
[TBL] [Abstract][Full Text] [Related]
28. Daptomycin in bone and joint infections: a review of the literature.
Rice DA; Mendez-Vigo L
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
[TBL] [Abstract][Full Text] [Related]
29. Fusidic acid in orthopaedic infections due to coagulase-negative staphylococci.
Coombs RR; Menday AP
Curr Med Res Opin; 1985; 9(9):587-90. PubMed ID: 3902374
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak A; Mundy LM
Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
[No Abstract] [Full Text] [Related]
31. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
Mason BW; Howard AJ
Int J Antimicrob Agents; 2004 Mar; 23(3):300-3. PubMed ID: 15164973
[TBL] [Abstract][Full Text] [Related]
32. Treatment of experimental osteomyelitis by methicillin resistant Staphylococcus aureus with bone cement system releasing grepafloxacin.
Efstathopoulos N; Giamarellos-Bourboulis E; Kanellakopoulou K; Lazarettos I; Giannoudis P; Frangia K; Magnissalis E; Papadaki M; Nikolaou VS
Injury; 2008 Dec; 39(12):1384-90. PubMed ID: 18656187
[TBL] [Abstract][Full Text] [Related]
33. [New therapeutic strategies with teicoplanin].
Carbone E; Nacinovich F; Stamboulian D
Medicina (B Aires); 2002; 62 Suppl 2():25-9. PubMed ID: 12481485
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy of acute bone and joint infections.
Bajpai J; Chaturvedi SN; Khanuja SP
Int Surg; 1977 Mar; 62(3):172-4. PubMed ID: 323174
[TBL] [Abstract][Full Text] [Related]
35. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D
Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644
[TBL] [Abstract][Full Text] [Related]
36. [Guidelines for the management of bone and joint infections due to methicillin resistant staphylococci].
Stamboulian D; Di Stefano C; Nacinovich F; Pensotti C; Marin M; Carbone E;
Medicina (B Aires); 2002; 62 Suppl 2():5-24. PubMed ID: 12481484
[TBL] [Abstract][Full Text] [Related]
37. [Problems with teicoplanin in the treatment of osteoarticular infections caused by methicillin-resistant S. aureus].
Gómez J; Climent C; Herrero F; Ruano L
Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):567-8. PubMed ID: 1489810
[No Abstract] [Full Text] [Related]
38. [Child osteoarticular infections: statements and perspectives].
Cohen R; Grimprel E
Arch Pediatr; 2007 Oct; 14 Suppl 2():S79-80. PubMed ID: 17956822
[No Abstract] [Full Text] [Related]
39. [Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections].
Cohen R; Grimprel E
Arch Pediatr; 2007 Oct; 14 Suppl 2():S122-7. PubMed ID: 17956820
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of methicillin-resistant Staphylococcus epidermidis prosthetic joint infection with telavancin.
Kaushal R; Hassoun A
J Antimicrob Chemother; 2012 Aug; 67(8):2052-3. PubMed ID: 22544850
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
